Angela Chambery Selected Research

Angela Chambery Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 11/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2014
2	Inflammation (Inflammations) 12/2022 - 11/2019
2	Osteoarthritis 12/2022 - 05/2020
2	Melanoma (Melanoma, Malignant) 03/2021 - 10/2011
2	Colonic Neoplasms (Colon Cancer) 05/2019 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 02/2016 - 11/2014
2	Retinoblastoma (Glioblastoma, Retinal) 01/2015 - 05/2006
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Bacterial Infections (Bacterial Infection) 09/2023
1	Neuroinflammatory Diseases 02/2023
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 02/2023
1	Necrosis 08/2021
1	Multiple Myeloma 12/2020
1	Epilepsy (Aura) 01/2020
1	Leukemia 01/2020
1	AIDS-Related Complex (ARC) 10/2019
1	Carcinogenesis 01/2019
1	Glioma (Gliomas) 05/2017
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017
1	Dementia (Dementias) 11/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2014
1	Amyloid Plaque 11/2014
1	Acute-Phase Reaction 01/2013
1	Infections 08/2012
1	Neoplasm Metastasis (Metastasis) 10/2011
1	Hyperplasia 07/2011
1	Fatty Liver 11/2010
1	Obesity 11/2010
1	Hypersensitivity (Allergy) 01/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2023 - 05/2006
3	Monoclonal AntibodiesIBA 01/2023 - 09/2019
2	EnzymesIBA 01/2024 - 08/2012
2	Cetuximab (Erbitux)FDA Link 01/2023 - 09/2019
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2022 - 05/2020
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 05/2017
2	Peptides (Polypeptides)IBA 07/2018 - 01/2008
1	Cholinesterases (Cholinesterase)IBA 01/2024
1	Monoamine Oxidase (MAO)IBA 01/2024
1	Oxidoreductases (Dehydrogenase)IBA 01/2024
1	Cholinergic Agents (Cholinergics)IBA 01/2024
1	AphidicolinIBA 12/2023
1	Cyclic PeptidesIBA 12/2023
1	Pattern Recognition ReceptorsIBA 09/2023
1	RNA (Ribonucleic Acid)IBA 09/2023
1	nusinersenIBA 02/2023
1	Immunotoxins (Immunotoxin)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	GlycosaminoglycansIBA 12/2022
1	Antiviral Agents (Antivirals)IBA 08/2021
1	AntigensIBA 03/2021
1	EpitopesIBA 03/2021
1	Therapeutic UsesIBA 12/2020
1	NF-kappa B (NF-kB)IBA 12/2020
1	Glucosamine (Dona)IBA 05/2020
1	Analgesics (Analgesic Drugs)IBA 05/2020
1	ChondroitinIBA 05/2020
1	SirtuinsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Cystatin BIBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Cocaine (Cocaine HCl)IBA 10/2019
1	Macrophage Migration-Inhibitory FactorsIBA 09/2019
1	cycloartaneIBA 05/2019
1	GlycosidesIBA 05/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	MAP Kinase Kinase 4IBA 07/2018
1	Caspase 8 (Caspase-8)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 05/2017
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 01/2017
1	Apoptosis Inducing FactorIBA 01/2017
1	RutheniumIBA 01/2017
1	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Cyclophilin AIBA 01/2017
1	AnionsIBA 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016
1	Adenosine Monophosphate (AMP)IBA 02/2016
1	Amyloid beta-PeptidesIBA 11/2014
1	Protein CIBA 11/2014
1	Surface-Active Agents (Surfactants)IBA 11/2014
1	Amino Acids FDA Link 11/2014
1	Bortezomib (Velcade)FDA Link 10/2014
1	Complement System Proteins (Complement)IBA 01/2013
1	OsteopontinIBA 10/2011
1	AcidsIBA 11/2010
1	3,5-diiodothyronineIBA 11/2010
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2008
1	Sepharose (Agarose)IBA 01/2008
1	NickelIBA 01/2008

Therapy/Procedure

4	Therapeutics 02/2023 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2020
1	Hepatectomy 07/2011